Oncimmune announces new CEO and finance director as part of leadership shake-up
LONDON, UK: Oncimmune Holdings plc, a company that provides autoantibody profiling services to the pharma and biotech industry, has announced the appointment of Martin Gouldstone...
Oncimmune signs agreement with Augmenta Bioworks to discover therapeutic antibodies
LONDON: Oncimmune Holdings plc has signed a new master service agreement with Augmenta Bioworks Inc. to profile patient plasma samples and characterise therapeutic candidates discovered...